Jae-Chul Kim
Vorsitzender bei DONGWON ENTERPRISE CO.,LTD
Vermögen: 195 Mio $ am 31.05.2024
Profil
Jae-Chul Kim is currently the Chairman at Dongwon Enterprise Co., Ltd.
He previously held the position of Chairman at DONGWON INDUSTRIES Co., Ltd.
and was a Research Fellow at Pacific Pharmaceutical Co., Ltd.
Kim completed his undergraduate degree at Pukyong National University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
DONGWON INDUSTRIES CO., LTD
21,49% | 10.05.2024 | 7 742 020 ( 21,49% ) | 195 Mio $ | 31.05.2024 |
Aktive Positionen von Jae-Chul Kim
| Unternehmen | Position | Beginn |
|---|---|---|
| DONGWON ENTERPRISE CO.,LTD | Vorsitzender | 10.11.2004 |
Ehemalige bekannte Positionen von Jae-Chul Kim
| Unternehmen | Position | Ende |
|---|---|---|
| DONGWON INDUSTRIES CO., LTD. | Vorsitzender | - |
| PACIFICPHARMA CORP | Corporate Officer/Principal | - |
Ausbildung von Jae-Chul Kim
| Pukyong National University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| DONGWON INDUSTRIES CO., LTD. | Transportation |
| Private Unternehmen | 2 |
|---|---|
Dongwon Enterprise Co., Ltd.
 Dongwon Enterprise Co., Ltd. Air Freight/CouriersTransportation Dongwon Enterprise Co., Ltd. is a holding company, which provides business and investment management services for the Dongwon Group. It offers brand and portfolio management and business expansion support. The company was founded on April 16, 2001 and is headquartered in Seoul, South Korea. | Transportation |
Pacific Pharmaceutical Co., Ltd.
 Pacific Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Pacific Pharmaceutical Co. Ltd. is manufacturing of medicinal and pharmaceutical products. Its products include ethical medicine such as plasters used in damaged bones, skins, sinews and fleshes, gastrological medicines, athletes foot remedies, antiphlogistics, liver remedies, antibiotics and antacids, anti-inflammatory analgesics and diabetes and circulatory remedies. It was founded on December 16, 1982 and is headquartered in Seoul, South Korea. | Health Technology |
